Skip to content
Genepowerx Blog

Genepowerx Blog

Menu

  • Blog
  • GenepoweRx
  • ATGC Life
  • News
  • Contact Us

How fitness genomics can improve your fitness performance regimen

How fitness genomics can improve your fitness performance regimen

What is fitness genomics? Fitness genomics involves genetic testing and counselling of an individual to learn more about their genes that are associated with one’s fitness. Information obtained from the fitness genomics can help design your fitness routine and thus

admin-gpxBlog November 28, 2022December 14, 2022 Uncategorized No Comments Read more

Why genetic testing is recommended for well-being?

Why genetic testing is recommended for well-being?

Genetic testing involves various types of medical tests that can detect changes in genes, chromosomes, and proteins. Currently, there are over 77,000 genetic tests which help in determining an individual’s predisposition to developing or passing on a genetic disorder to

admin-gpxBlog November 25, 2022December 14, 2022 Blog No Comments Read more

What makes GenepoweRx the preferred genetic testing company for doctors?

What makes GenepoweRx the preferred genetic testing company for doctors?

Genetic testing is the new buzzword that is doing the rounds these days in the medical field. The advancements in genetics have paved the way for genetic testing and awareness about it is spreading like wildfire. Genetic testing means looking

admin-gpxBlog November 25, 2022December 14, 2022 Blog No Comments Read more

Monoclonal Antibody Therapy Defeats/Overcomes Migraine Remedy Failure

Monoclonal Antibody Therapy Defeats/Overcomes Migraine Remedy Failure

A recent clinical trial, that was originally published in The Lancet Neurology, found that people whose previous treatments for migraine headaches had failed, found a great relief with monoclonal antibody eptinezumab. The trial was performed to examine whether intravenously administered

admin-gpxBlog November 21, 2022December 14, 2022 News No Comments Read more

First Targeted Therapy Approved for ERBB2-low Breast Cancer

First Targeted Therapy Approved for ERBB2-low Breast Cancer

The very first targeted therapy for epidermal growth factor receptor 2 (ERBB2, formerly known as HER 2)–low breast cancer has got Food and Drug Administration (FDA) approval. JAMA Network published this news from the FDA. Breast cancer cells with higher-than-normal

admin-gpxBlog November 21, 2022December 14, 2022 News No Comments Read more

Cortactin and HER2 as Potential Dural-Targeted Therapy Markers in Advanced Gastric Cancer

Cortactin and HER2 as Potential Dural-Targeted Therapy Markers in Advanced Gastric Cancer

Co-overexpression (Overexpression – The abnormal expression of a gene in increased quantity) of HER2/cortactin proteins were found to be an important predictive biomarker for gastric cancer (GC) patients, according to the study published in the Clinical and Experimental Medicine. The

admin-gpxBlog November 20, 2022December 14, 2022 News No Comments Read more

Nutrigenomics- Genetic testing for prescription of diet that support long life

Nutrigenomics- Genetic testing for prescription of diet that support long life

Nutrigenomics, also called as nutritional genomics, is a newly emerging field based on the unique relationship between gene expression, nutrients, and diet. With the completion of the Human Genome Project, the field of nutrigenomics gained an impetus. It lays the

admin-gpxBlog November 19, 2022November 19, 2022 Blog No Comments Read more

Recent Posts

  • Why genetic testing is recommended for well-being?
  • What makes GenepoweRx the preferred genetic testing company for doctors?
  • Nutrigenomics- Genetic testing for prescription of diet that support long life

Latest News

  • Monoclonal Antibody Therapy Defeats/Overcomes Migraine Remedy Failure
  • First Targeted Therapy Approved for ERBB2-low Breast Cancer
  • Cortactin and HER2 as Potential Dural-Targeted Therapy Markers in Advanced Gastric Cancer
Copyright © 2023 Genepowerx Blog. All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.